Innovent Biologics (IVBXF)
OTHER OTC:IVBXF
Holding IVBXF?
Track your performance easily

Innovent Biologics (IVBXF) Balance Sheet

32 Followers

Innovent Biologics Balance Sheet

Innovent Biologics's total assets for Q2 2022 were ¥16.16B, a decrease of -0.52% from the previous quarter. IVBXF total liabilities were ¥― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Assets
¥ 16.24B¥ 11.83B¥ 7.23B¥ 6.11B¥ 2.46B
Total Liabilities
-----
Total Equity Gross Minority
¥ 10.33B¥ 8.78B¥ 4.76B¥ 4.19B¥ -1.62B
Total Capitalization
¥ 12.35B¥ 9.70B¥ 5.56B¥ 4.98B¥ -1.44B
Preferred Stock Equity
-----
Capital Lease Obligations
¥ 108.67M¥ 26.39M¥ 40.09M¥ 0.00-
Currency in CNY

Innovent Biologics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis